165 related articles for article (PubMed ID: 35486030)
61. BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
Wiles ET; Lui-Sargent B; Bell R; Lessnick SL
PLoS One; 2013; 8(3):e59369. PubMed ID: 23527175
[TBL] [Abstract][Full Text] [Related]
62. Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma.
Toub N; Bertrand JR; Tamaddon A; Elhamess H; Hillaireau H; Maksimenko A; Maccario J; Malvy C; Fattal E; Couvreur P
Pharm Res; 2006 May; 23(5):892-900. PubMed ID: 16715379
[TBL] [Abstract][Full Text] [Related]
63. LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 Stability.
Keskin T; Bakaric A; Waszyk P; Boulay G; Torsello M; Cornaz-Buros S; Chevalier N; Geiser T; Martin P; Volorio A; Iyer S; Kulkarni A; Letovanec I; Cherix S; Cote GM; Choy E; Digklia A; Montemurro M; Chebib I; Nielsen PG; Carcaboso AM; Mora J; Renella R; Suvà ML; Fusco C; Provero P; Rivera MN; Riggi N; Stamenkovic I
Cell Rep; 2020 Mar; 30(13):4567-4583.e5. PubMed ID: 32234488
[TBL] [Abstract][Full Text] [Related]
64. Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.
Jedlicka P
Int J Clin Exp Pathol; 2010 Mar; 3(4):338-47. PubMed ID: 20490326
[TBL] [Abstract][Full Text] [Related]
65. Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood.
Notarangelo M; Zucal C; Modelska A; Pesce I; Scarduelli G; Potrich C; Lunelli L; Pederzolli C; Pavan P; la Marca G; Pasini L; Ulivi P; Beltran H; Demichelis F; Provenzani A; Quattrone A; D'Agostino VG
EBioMedicine; 2019 May; 43():114-126. PubMed ID: 31047861
[TBL] [Abstract][Full Text] [Related]
66. Plasma hydrogenated cationic detonation nanodiamonds efficiently deliver to human cells in culture functional siRNA targeting the Ewing sarcoma junction oncogene.
Bertrand JR; Pioche-Durieu C; Ayala J; Petit T; Girard HA; Malvy CP; Le Cam E; Treussart F; Arnault JC
Biomaterials; 2015 Mar; 45():93-8. PubMed ID: 25662499
[TBL] [Abstract][Full Text] [Related]
67. Enabling Sensitive Phenotypic Profiling of Cancer-Derived Small Extracellular Vesicles Using Surface-Enhanced Raman Spectroscopy Nanotags.
Zhang W; Jiang L; Diefenbach RJ; Campbell DH; Walsh BJ; Packer NH; Wang Y
ACS Sens; 2020 Mar; 5(3):764-771. PubMed ID: 32134252
[TBL] [Abstract][Full Text] [Related]
68. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
[TBL] [Abstract][Full Text] [Related]
69. Looking downstream of sarcoma-associated chimeric transcription factors: when is a target really a target?
Mercado GE; Barr FG
Cancer Biol Ther; 2005 Apr; 4(4):456-8. PubMed ID: 15908795
[No Abstract] [Full Text] [Related]
70. Exploration of Flavonoids as Lead Compounds against Ewing Sarcoma through Molecular Docking, Pharmacogenomics Analysis, and Molecular Dynamics Simulations.
Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Hassan M; Kloczkowski A; Chun W
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615603
[TBL] [Abstract][Full Text] [Related]
71. Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.
Selvanathan SP; Graham GT; Erkizan HV; Dirksen U; Natarajan TG; Dakic A; Yu S; Liu X; Paulsen MT; Ljungman ME; Wu CH; Lawlor ER; Üren A; Toretsky JA
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1307-16. PubMed ID: 25737553
[TBL] [Abstract][Full Text] [Related]
72. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer.
Sanchez G; Bittencourt D; Laud K; Barbier J; Delattre O; Auboeuf D; Dutertre M
Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6004-9. PubMed ID: 18413612
[TBL] [Abstract][Full Text] [Related]
73. C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells.
Gardiner JD; Abegglen LM; Huang X; Carter BE; Schackmann EA; Stucki M; Paxton CN; Lor Randall R; Amatruda JF; Putnam AR; Kovar H; Lessnick SL; Schiffman JD
Oncotarget; 2017 Apr; 8(16):26013-26026. PubMed ID: 28148901
[TBL] [Abstract][Full Text] [Related]
74. Pharmaceutical Interference of the EWS-FLI1-driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma.
Heisey DAR; Jacob S; Lochmann TL; Kurupi R; Ghotra MS; Calbert ML; Shende M; Maves YK; Koblinski JE; Dozmorov MG; Boikos SA; Benes CH; Faber AC
Mol Cancer Ther; 2021 Oct; 20(10):1868-1879. PubMed ID: 34315769
[TBL] [Abstract][Full Text] [Related]
75. Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.
Yuan B; Ji W; Xia H; Li J
Mol Med Rep; 2018 Mar; 17(3):4291-4298. PubMed ID: 29328472
[TBL] [Abstract][Full Text] [Related]
76. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
[TBL] [Abstract][Full Text] [Related]
77. EWSR1 fusion proteins mediate PAX7 expression in Ewing sarcoma.
Charville GW; Wang WL; Ingram DR; Roy A; Thomas D; Patel RM; Hornick JL; van de Rijn M; Lazar AJ
Mod Pathol; 2017 Sep; 30(9):1312-1320. PubMed ID: 28643791
[TBL] [Abstract][Full Text] [Related]
78. Mithramycin A Radiosensitizes EWS:Fli1
Lin MY; Damron TA; Oest ME; Horton JA
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1454-1471. PubMed ID: 33373655
[TBL] [Abstract][Full Text] [Related]
79. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.
Giorgi C; Boro A; Rechfeld F; Lopez-Garcia LA; Gierisch ME; Schäfer BW; Niggli FK
Oncotarget; 2015 Oct; 6(30):28895-910. PubMed ID: 26336820
[TBL] [Abstract][Full Text] [Related]
80. Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship.
Ceranski AK; Carreño-Gonzalez MJ; Ehlers AC; Colombo MV; Cidre-Aranaz F; Grünewald TGP
Mol Cancer; 2023 Mar; 22(1):49. PubMed ID: 36915100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
